Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2012-11-16 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: OIGNIES (62590), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE MAIRE : revenue, balance sheet and financial ratios
SELARL PHARMACIE MAIRE is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in OIGNIES (62590),
this company of category PME
shows in 2025 a net income positive of 85 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE MAIRE (SIREN 789430139)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
84 638 €
100 474 €
73 184 €
145 506 €
95 981 €
82 741 €
78 944 €
150 171 €
158 848 €
-20 809 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE MAIRE generates positive net income of 85 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
84 638 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 74%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
73.703%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.813%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
632.747
363.314
245.67
236.429
240.502
209.753
153.293
124.265
99.228
73.703
Financial autonomy
12.312
18.355
24.866
26.117
25.685
28.657
34.034
36.427
42.849
46.813
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
73.72025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-6 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE MAIRE (73.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.81%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+7 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE MAIRE (46.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 139.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
136.849
122.816
142.135
150.504
213.185
244.453
215.19
168.426
171.618
139.081
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
139.082025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-11 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE MAIRE (139.08) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE MAIRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE MAIRE is estimated at
1 344 484 €
(range 912 373€ - 2 109 681€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
912k€1344k€2109k€
1 344 484 €Range: 912 373€ - 2 109 681€
NAF 5 année 2025
Valuation method used
Net Income Multiple
84 638 €
×
15.9x
=1 344 485 €
Range: 912 374€ - 2 109 682€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE MAIRE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE MAIRE
What is the revenue of SELARL PHARMACIE MAIRE ?
The revenue of SELARL PHARMACIE MAIRE is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE MAIRE profitable?
Yes, SELARL PHARMACIE MAIRE generated a net profit of 85 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE MAIRE ?
The headquarters of SELARL PHARMACIE MAIRE is located in OIGNIES (62590), in the department Pas-de-Calais.
Where to find the tax return of SELARL PHARMACIE MAIRE ?
The tax return of SELARL PHARMACIE MAIRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE MAIRE operate?
SELARL PHARMACIE MAIRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart